Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
3.690
-0.130 (-3.40%)
At close: Dec 20, 2024, 4:00 PM
3.770
+0.080 (2.17%)
After-hours: Dec 20, 2024, 5:00 PM EST
Achieve Life Sciences Employees
Achieve Life Sciences had 22 employees as of December 31, 2023. The number of employees increased by 2 or 10.00% compared to the previous year.
Employees
22
Change (1Y)
2
Growth (1Y)
10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,497,409
Market Cap
126.90M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Nevro | 1,215 |
| Akoya Biosciences | 330 |
| Jin Medical International | 245 |
| Protalix BioTherapeutics | 208 |
| Compugen | 68 |
| PepGen | 64 |
| Monopar Therapeutics | 10 |
| Telomir Pharmaceuticals | 9 |
ACHV News
- 12 days ago - Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer - GlobeNewsWire
- 18 days ago - Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA - GlobeNewsWire
- 26 days ago - Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma) - GlobeNewsWire
- 5 weeks ago - Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Achieve Life Sciences, Inc. (ACHV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs - GlobeNewsWire